991 related articles for article (PubMed ID: 32678460)
21. HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome.
Gigli GL; Vogrig A; Nilo A; Fabris M; Biasotto A; Curcio F; Miotti V; Tascini C; Valente M
Neurol Sci; 2020 Dec; 41(12):3391-3394. PubMed ID: 33006723
[TBL] [Abstract][Full Text] [Related]
22. Guillain-Barré syndrome following COVID-19: new infection, old complication?
Padroni M; Mastrangelo V; Asioli GM; Pavolucci L; Abu-Rumeileh S; Piscaglia MG; Querzani P; Callegarini C; Foschi M
J Neurol; 2020 Jul; 267(7):1877-1879. PubMed ID: 32333166
[No Abstract] [Full Text] [Related]
23. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.
Dalakas MC
Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32518172
[TBL] [Abstract][Full Text] [Related]
24. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
[TBL] [Abstract][Full Text] [Related]
25. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review.
Diez-Porras L; Vergés E; Gil F; Vidal MJ; Massons J; Arboix A
Neuromuscul Disord; 2020 Oct; 30(10):859-861. PubMed ID: 32912716
[TBL] [Abstract][Full Text] [Related]
26. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports.
Rahimi K
Neurol Sci; 2020 Nov; 41(11):3149-3156. PubMed ID: 32876777
[TBL] [Abstract][Full Text] [Related]
27. Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK.
Tiet MY; AlShaikh N
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641309
[TBL] [Abstract][Full Text] [Related]
28. Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review.
Trujillo Gittermann LM; Valenzuela Feris SN; von Oetinger Giacoman A
Neurologia (Engl Ed); 2020; 35(9):646-654. PubMed ID: 32896460
[TBL] [Abstract][Full Text] [Related]
29. Guillain-Barré Syndrome in a Patient With Minimal Symptoms of COVID-19 Infection.
Oguz-Akarsu E; Ozpar R; Mirzayev H; Acet-Ozturk NA; Hakyemez B; Ediger D; Karli N;
Muscle Nerve; 2020 Sep; 62(3):E54-E57. PubMed ID: 32497292
[No Abstract] [Full Text] [Related]
30. Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection: A Case Report and Review of the Literature.
Paybast S; Gorji R; Mavandadi S
Neurologist; 2020 Jul; 25(4):101-103. PubMed ID: 32618839
[TBL] [Abstract][Full Text] [Related]
31. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
[TBL] [Abstract][Full Text] [Related]
32. Guillain-Barré Syndrome after Novel Coronavirus Disease 2019.
Yakoby J; Litvak I; Yu E
J Emerg Med; 2021 Oct; 61(4):e67-e70. PubMed ID: 34103203
[TBL] [Abstract][Full Text] [Related]
33. COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up.
Ahmad L; Businaro P; Regalbuto S; Gastaldi M; Zardini E; Panzeri M; Vegezzi E; Fiamingo G; Colombo E; Ravaglia S
Medicine (Baltimore); 2022 Jul; 101(30):e29704. PubMed ID: 35905215
[TBL] [Abstract][Full Text] [Related]
34. Spectrum of Neurological Manifestations in Covid-19: A Review.
Garg RK
Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
[TBL] [Abstract][Full Text] [Related]
35. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
Cea G; Romero C; Aguilar S; Salinas R
Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with a favourable outcome.
Lascano AM; Epiney JB; Coen M; Serratrice J; Bernard-Valnet R; Lalive PH; Kuntzer T; Hübers A
Eur J Neurol; 2020 Sep; 27(9):1751-1753. PubMed ID: 32478936
[TBL] [Abstract][Full Text] [Related]
37. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
[TBL] [Abstract][Full Text] [Related]
38. Guillain-Barré syndrome associated with SARS-CoV-2 infection. Comments after 16 published cases.
Guijarro-Castro C; Rosón-González M; Abreu A; García-Arratibel A; Ochoa-Mulas M
Neurologia (Engl Ed); 2020; 35(6):412-415. PubMed ID: 32565036
[No Abstract] [Full Text] [Related]
39. Concomitant Guillain-Barre syndrome with COVID-19: a case report.
Mackenzie N; Lopez-Coronel E; Dau A; Maloof D; Mattar S; Garcia JT; Fontecha B; Lanata CM; Guillen-Burgos HF
BMC Neurol; 2021 Mar; 21(1):135. PubMed ID: 33757457
[TBL] [Abstract][Full Text] [Related]
40. Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report.
Riva N; Russo T; Falzone YM; Strollo M; Amadio S; Del Carro U; Locatelli M; Filippi M; Fazio R
J Neurol; 2020 Sep; 267(9):2492-2494. PubMed ID: 32458192
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
